Tobacco Treatment in the Context of Lung Cancer Screening Task Group
Task Group Charge:
Guided by best practices, research findings and engagement with key stakeholders, the charge is to develop blueprints for integrating and monitoring success of implementing evidence-based tobacco treatment in the workflow of lung cancer screening.
Task Group Members
Thomas Boyle
Patient Advocate, Seattle Cancer Care Alliance
Paul Cinciripini, PhD
University of Texas MD Anderson Cancer Center
Angela Criswell, MA
GO2 Foundation for Lung Cancer
Neal Freedman, MD, MPH
National Cancer Institute
S. Jane Henley, MSPH
Centers for Disease Control and Prevention
Jonathon Hontzas, AGACNP-BC, DNP
University of Mississippi Medical Center
Thomas Houston, MD*
The Ohio State University
Hasmeena Kathuria, MD
Boston University
Stephanie Land, PhD
National Cancer Institute
Elyse Park, PhD, MPH
Massachusetts General Hospital
(*) indicates Steering Committee member
Bradley Pua, MD
Weill Cornell Medicine
Thomas Richards, MD
Centers for Disease Control and Prevention
Theresa Roelke, MSN
Maine Medical Center
Peter Shields, MD
The Ohio State University
Kathryn Taylor, PhD
Lombardi Comprehensive Cancer Center
Benjamin Toll, PhD
Medical University of South Carolina
Brenna VanFrank, MD, MSPH
Centers for Disease Control and Prevention
Graham Warren, MD, PhD
Medical University of South Carolina
Opportunities For Intervention/Influence:
- Summarize current literature/seminal papers/allied initiatives
- Conduct and disseminate findings from a national representative survey of current practices, organizational priority, and perceived barriers for tobacco cessation treatment delivery from stratified random sample of ACR (and/or LCA) designated lung cancer screening sites.
- Identify and address barriers for implementation of evidence-based smoking cessation treatment in the context of lung cancer screening.
- Create blueprints for integrating smoking cessation advice and treatment in the context of lung cancer screening workflow across various lung cancer screening settings, including encounters with the referring healthcare professional, both when discussing screening and when discussing the results.
- Develop and promote use of quality metrics for smoking cessation treatment process and outcomes in the context of lung cancer screening Create toolkit for integration of smoking cessation in lung cancer screening
- Create toolkit for integration of smoking cessation in lung cancer screening, for instance:
- Staff training/Provider education and tools (evidence based pharmacologic and non-pharmacologic treatments, billing and coding, and policies around reimbursement)
- Electronic health record modules (treatment reference resources, templates, order sets)
- Patient education and support tools